The Biobanking Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
A biobank is a place where biological materials that are connected to clinical data are stored. These samples are collected, handled, kept, and processed in compliance with quality standards to benefit society in some kind of a non-profit manner and to promote biomedical research. Large collections of information and biological samples known as biobanks were built specifically for the study. In a number of industries, which would include pharma, academic institutions, livestock breeding, and charitable foundations, these repositories are essential again for advances in medical science into illnesses pathologies as well as demographically experiments within areas of epigenetic mechanisms, preventive services medical programs, chronic illnesses, and epidemiology. Tumor specimens, umbilical, blood, and cerebral spinal fluid are just a few of the several places where biospecimens can be found.
Biobanks Have Emerged Due to Enormous Growth in Scientific Production in Biomedicine During the Past Five Years
Biobanks have increased in size, number, and in some respects, speciation. Biospecimen source guides today include hundreds of biobanks, each with a unique business model for gathering, storing, disseminating, tagging, categorizing, and analyzing specimens (mostly originating from humans) for scientific study. The necessity to combine fundamental and clinical research by promoting cooperative models and the potential to boost informed consent effectiveness because the same genetic material may be used for different purposes led to the emergence of biobanks during the last five years.
What Questions Should You Ask before Buying a Market Research Report?
• How is the biobanking market evolving?
• What is driving and restraining the biobanking market?
• How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each biobanking submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biobanking projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of biobanking projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the biobanking market?
• Where is the biobanking market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biobanking market today, and over the next 10 years:
• Our 553-page report provides 359 tables and 317 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains an in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biobanking prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Type
• Standalone
• Partnership
Market Segment by Application
• Regenerative Medicine
• Life Science Research
• Clinical Research
Market Segment by Ownership
• National/ Regional
• Universities
• Non-Profit
• Private
Market Segment by Sample Type
• Blood Products
• Human Tissues
• Nucleic Acids
• Cell Lines
• Biological Fluids
• Other Samples
Market Segment by Product and Service
• Equipment
• Consumables
• Services
• Software
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Finland
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Singapore
• Australia
• Rest of Asia Pacific
LAMEA
• Brazil
• Qatar
• Saudi Arabia
• Egypt
• Mexico
• Rest of Latin America
The report also includes profiles and for some of the leading companies in the Biobanking Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AMS Biotechnology (Europe) Ltd.
• ASKION GmbH
• Avantor, Inc.
• Azenta, Inc. (Azenta)
• Bay Biosciences LLC
• Bioivt & Elevating Science
• Boca Biolistics
• CTI Biotech
• Cureline Inc.
• Firalis SA
• Geneticist Inc.
• Hamilton Bonaduz AG
• Isenet Biobanking
• Merck & Co., Inc.
• ProteoGenex Inc.
• Qiagen NV
• Stemcell Holdings, Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• US Biolab Corp. Inc.
Overall world revenue for Biobanking Market, 2022 to 2032 in terms of value the market will surpass US$59,347 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biobanking Market, 2022 to 2032 report help you?
In summary, our 550+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Biobanking Market, 2022 to 2032 Market, with forecasts for type, application, sample type, ownership, product and service, and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Biobanking Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Biobanking Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Biobanking Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
'
1 Report Overview
1.1 Introduction to Biobanking Market
1.2 What are the Objectives of this Report?
1.3 What is the Scope of the Report?
1.4 Biobanking Market Definition
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Reports
1.12 About
2 Executive Summary
3 Biobanking Industry Structure
3.1 Overview
3.1.1 What is Biobank
3.1.2 Key features
3.1.3 Main Components of Biobanking
3.1.4 Types of Samples Collected in Biobanks
3.1.5 Types of Biobanks
3.1.6 History of Biobanks
3.1.7 Biobanking Operations
3.1.8 Objectives of a Biobank
3.1.9 Variability in Biobanks
3.1.10 Setting up a Biobank may be Difficult Given the Complexities of Biospecimen Handling And Maintenance
3.1.11 Biobanking in Health Care: Evolution and Future Directions
4 Global Market Dynamics
4.1 Current Trends in the Global Market
4.1.1 Investment in Information Communication Technologies to Drive Market Growth
4.1.2 Commercialisation of Biobanks’ Brings a Number of Potential Benefits
4.2 Market Driving Factors
4.2.1 Increased Focus on Precision Medicine and Genetic Testing
4.2.2 Growing Demand for Umbilical Cord Blood Banking
4.2.3 Evolution of Biobanks Rapidly Enabling Creation of Massive Collections of Biological Materials and Associated Information
4.3 Market Restraining Factors
4.3.1 Private Sponsorship Has Raised a Number of Ethical Issues
4.3.2 Issues Related to Biospecimen Sample Procurement
4.3.3 Challenges Related to Variability in Biobanks
4.4 Opportunities in the Global Market
4.4.1 Opportunities for Cardiovascular Research
4.4.2 The Pandemic Has Changed All Aspects of Biobanking Industry
4.4.3 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
4.4.4 Growing Focus on the R&D of Cell Therapies
4.5 Challenges in the Global Market
4.5.1 Long-Term Sustainability of Biobanks
4.5.2 Biobanks Facing Familiar Challenges of Improving Design with Limited Resources
4.5.3 Academic Clinical Biobank's Business Plan Should Contain Risk Management and Risk Prognosis
4.6 SWOT Analysis for Global Market
5 Global Biobanking Market Analysis
5.1 Global Market Outlook
5.1.1 List of Biobanks Globally
5.2 Global Market Size Estimation and Forecast
5.2.1 Pre-COVID-19 Market Scenario
5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Region
6.1 Pre-COVID-19 Market Scenario
6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast Biobank Type
7.1 Standalone
7.2 Partnership
7.3 Pre-COVID-19 Market Scenario
7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and by Application
8.1 Regenerative Medicine
8.2 Life Science Research
8.3 Clinical Research
8.3.1 Treatment Research
8.3.2 Prevention Research
8.3.3 Diagnostic Research
8.3.4 Screening Research
8.3.5 Quality of Life Research
8.3.6 Genetic studies
8.3.7 Epidemiological studies
8.4 Pre-COVID-19 Market Scenario
8.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast by Ownership
9.1 National/ Regional
9.2 Universities
9.3 Private
9.4 Pre-COVID-19 Market Scenario
9.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast by Sample Type
10.1 Blood Products
10.2 Human Tissues
10.3 Nucleic Acids
10.4 Cell Lines
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Market Size Estimation and Forecast Product and Service
11.1 Equipment
11.2 Consumables
11.3 Services
11.4 Software
11.5 Pre-COVID-19 Market Scenario
11.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Biobanking Market Analysis
12.1 North America Market Size Estimation and Forecast
12.1.1 Pre-COVID-19 Market Scenario
12.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 North America Market Size Estimation and Forecast by Country
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 North America Market Size Estimation and Forecast Type
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and by "Application
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by Ownership
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Sample Type
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast Product and Service
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 U.S. Biobanking Market Analysis
12.8.1 Biobanking Research and Privacy Laws in the United States
12.8.2 BioLife Solutions Executes Co-Marketing Agreement with Coriell Institute
12.8.3 Pre-COVID-19 Market Scenario
12.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Canada Biobanking Market Analysis
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Biobanking Market Analysis
13.1 Europe Market Outlook
13.1.1 REPROCELL Signs Agency Agreement with Ajinomoto Group for the Marketing and Sales of StemFit Basic03 GMP
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Europe Market Size Estimation and Forecast by Country
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and by Application
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Ownership
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Sample Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast Product and Service
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Germany Biobanking Market Analysis
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 UK Biobanking Market Analysis
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 France Biobanking Market Analysis
13.11.1 Pre-COVID-19 Market Scenario
13.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Italy Biobanking Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Spain Biobanking Market Analysis
13.13.1 Pre-COVID-19 Market Scenario
13.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Russia Biobanking Market Analysis
13.14.1 Pre-COVID-19 Market Scenario
13.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Denmark Biobanking Market Analysis
13.15.1 Denmark Launches World-Class Biobank
13.15.2 Pre-COVID-19 Market Scenario
13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.16 Finland Biobanking Market Analysis
13.16.1 FINGENIOUS® – A Digital Gateway to Finnish Biobanks And Biomedical Research
13.16.2 Pre-COVID-19 Market Scenario
13.16.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.17 Rest of Europe Biobanking Market Analysis
13.17.1 Switzerland Seeking to Join Six European Infrastructure Networks
13.17.2 Pre-COVID-19 Market Scenario
13.17.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Biobanking Market Analysis
14.1 Asia-Pacific Market Outlook
14.1.1 Six Government Agencies Work Together to Run the Korean Public Biobanks
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Asia-Pacific Market Size Estimation and Forecast by Country
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and by "Application
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Ownership
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Sample Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Product and Service
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 China Biobanking Market Analysis
14.9.1 Rapid Expansion of Biobanking in China
14.9.2 Pre-COVID-19 Market Scenario
14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 India Biobanking Market Analysis
14.10.1 Sapien Biosciences: India’s First Commercial Biobank That Helps Develop Novel Diagnostic Tests and Cures
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Japan Biobanking Market Analysis
14.11.1 Nightingale and BioBank Japan to Realise Personalised Medicine and Preventative Health in Japan
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Singapore Biobanking Market Analysis
14.12.1 Established Biobank in Singapore
14.12.2 BioBank - National Heart Centre Singapore
14.12.3 Pre-COVID-19 Market Scenario
14.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 Australia Biobanking Market Analysis
14.13.1 Australia’s First Accredited Biobank
14.13.2 NATA’s Biobanking Accreditation Set to Expand the Emerging Australian Biobanking Industry
14.13.3 Pre-COVID-19 Market Scenario
14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Rest of Asia-Pacific Biobanking Market Analysis
14.14.1 Taiwan Biobank: A Rich Biomedical Research Database of the Taiwanese Population
14.14.2 Pre-COVID-19 Market Scenario
14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Biobanking Market Analysis
15.1 LAMEA Market Outlook
15.1.1 Tumor Banking for Health Research in Brazil and Latin America
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 LAMEA Market Size Estimation and Forecast by Country
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast Type
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and by Application
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Ownership
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Sample Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast Product and Service
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 Egypt Biobanking Market Analysis
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Qatar Biobanking Market Analysis
15.10.1 Qatar Biobank Launches Online Portal to Provide Researchers with Bio-samples
15.10.2 Qatar Biobank research helps more than 190 projects
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 Mexico Biobanking Market Analysis
15.11.1 Trans-Hit Bio Has Established New Collaborations With Mexican Biobanks
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.1 Brazil Biobanking Market Analysis
15.1.1 Current State of Biobanking Activities in Brazil
15.1.2 Pre-COVID-19 Market Scenario
15.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.2 Saudi Arabia Biobanking Market Analysis
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Rest of LAMEA Biobanking Market Analysis
15.3.1 Urgent Need for Management of Biological Samples and Data Accessibility in Latin America
15.3.2 Pre-COVID-19 Market Scenario
15.3.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles
16.1 QIAGEN
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.2 Merck & Co., Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.3 Avantor Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 STEMCELL Technologies Inc
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Product Benchmarking
16.4.4 Company Recent Developments
16.5 Stemcell Holdings, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Product Benchmarking
16.6 Azenta Life Sciences
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financial Profile
16.6.4 Company Product Benchmarking
16.6.5 Company Recent Developments
16.7 AMS Biotechnology (Europe) Ltd.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Product Benchmarking
16.7.4 Company Recent Developments
16.8 ASKION GmbH
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Product Benchmarking
16.8.4 Company Recent Developments
16.9 Bay Biosciences LLC
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Product Benchmarking
16.9.4 Company Recent Developments
16.10 Cureline Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Product Benchmarking
16.10.4 Company Recent Developments
16.11 Firalis SA.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Product Benchmarking
16.11.4 Company Recent Developments
16.12 Geneticist Inc..
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Product Benchmarking
16.12.4 Company Recent Developments
16.13 Hamilton Bonaduz AG
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Product Benchmarking
16.13.4 Company Recent Developments
16.14 ProteoGenex Inc.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Product Benchmarking
16.14.4 Company Recent Developments
16.15 Thermo Fisher Scientific Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financial Profile
16.15.4 Company Product Benchmarking
16.15.5 Company Recent Developments
16.16 US Biolab Corp. Inc.
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Product Benchmarking
16.17 BIOIVT & ELEVATING SCIENCE
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Product Benchmarking
16.17.4 Company Recent Developments
16.18 Boca Biolistics
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Company Product Benchmarking
16.18.4 Company Recent Developments
16.19 CTI Biotech
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Company Product Benchmarking
16.19.4 Company Recent Developments
16.20 Isenet Biobanking
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Company Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations for Market Players
List of Tables
Table 1. Global Biobanking Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2. Biobanking Market Swot Analysis
Table 3. Largest Biobanking In The World
Table 4. List of Europe Biobank
Table 5. List of North and Canada Biobanking
Table 6. List of Asian Biobanks
Table 7. Global Bio banking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 8. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 10. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 11. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 12. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 13. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 15. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 16. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 17. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 18. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 20. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 21. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 22. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 23. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 25. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 26. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 27. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 28. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 30. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 31. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 32. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 33. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 35. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 36. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 37. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 38. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 40. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 41. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 42. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 43. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 45. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 46. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 47. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 48. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 50. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 51. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 52. North America Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 53. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 55. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 56. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 57. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 58. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 60. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 61. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 62. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 63. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 65. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 66. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 67. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 68. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 70. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 71. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 72. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 73. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 75. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 76. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 77. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 78. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 80. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 81. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 82. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 83. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 84. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 85. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 86. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 87. Europe Bio banking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 88. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 89. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 90. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 91. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 92. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 93. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 94. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 95. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 96. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 97. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 98. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 99. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 100. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 101. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 102. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 103. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 105. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 106. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 107. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 108. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 110. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 111. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 112. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 113. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 115. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 116. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 117. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 118. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 120. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 121. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 122. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 123. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 125. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 126. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 127. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 128. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 130. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 131. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 132. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 133. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 135. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 136. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 137. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 138. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 139. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 140. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 141. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 142. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 143. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 144. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 145. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 146. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 147. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 148. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 149. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 150. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 151. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 152. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 153. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 154. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 155. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 156. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 157. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 158. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 160. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 161. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 162. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 163. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 165. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 166. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 167. List of Asian Biobanks
Table 168. Korean Biobank List
Table 169. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 170. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 171. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 172. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD
